193 related articles for article (PubMed ID: 30602952)
1. Interleukin-6 gene -572G/C polymorphism and prostate cancer risk.
Wang Y; Chen X; Chen Y
Afr Health Sci; 2018 Jun; 18(2):267-272. PubMed ID: 30602952
[TBL] [Abstract][Full Text] [Related]
2. Association of the interleukin-6 gene -572G/C polymorphism with cancer risk: a meta-analysis.
Zhao Q; Zhang B; Chen Y; Li M; Zhao X; Fan H; Li SM
Genet Mol Res; 2015 Dec; 14(4):16921-8. PubMed ID: 26681039
[TBL] [Abstract][Full Text] [Related]
3. Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis.
An PP; Feng LN; Zhang XX; Jin QL
Medicine (Baltimore); 2020 Dec; 99(50):e23659. PubMed ID: 33327352
[TBL] [Abstract][Full Text] [Related]
4. Relationship between polymorphisms in -572G/C interleukin 6 promoter gene polymorphisms (rs1800796) and risk of rheumatoid arthritis: A meta-analysis.
Zhang C; Jiao S; Li T; Zhao L; Chen H
Int J Rheum Dis; 2020 Jan; 23(1):47-54. PubMed ID: 31782615
[TBL] [Abstract][Full Text] [Related]
5. Association between the interleukin-6 gene -572G/C and -597G/A polymorphisms and coronary heart disease in the Han Chinese.
Jia X; Tian Y; Wang Y; Deng X; Dong Z; Scafa N; Zhang X
Med Sci Monit; 2010 Mar; 16(3):CR103-108. PubMed ID: 20190679
[TBL] [Abstract][Full Text] [Related]
6. Association of IL-6-174 G/C and IL10-1082 G/A polymorphisms with recurrent aphthous stomatitis risk: A meta-analysis.
Yang S; Zhang B; Shi Q; Liu J; Xu J; Huo N
Medicine (Baltimore); 2017 Dec; 96(52):e9533. PubMed ID: 29384969
[TBL] [Abstract][Full Text] [Related]
7. Association between IL-18 -607 C/A Polymorphism and the Risk of Prostate Cancer: A Meta-Analysis of Case-Control Studies.
Yuanyuan G; Xue Y; Yachao L; Xiao F; Xu C
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1595-1602. PubMed ID: 31244277
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 -572G/C polymorphism and prostate cancer susceptibility.
Huang WJ; Wu LJ; Min ZC; Xu LT; Guo CM; Chen ZP; Lou XJ; Xu B; Lv BD
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706719
[TBL] [Abstract][Full Text] [Related]
9. Racial disparities in the association between diabetes mellitus-associated polymorphic locus rs4430796 of the HNF1β gene and prostate cancer: a systematic review and meta-analysis.
Xiang YZ; Jiang SB; Zhao J; Xiong H; Cui ZL; Li GB; Jin XB
Genet Mol Res; 2014 Aug; 13(3):6582-92. PubMed ID: 25177939
[TBL] [Abstract][Full Text] [Related]
10. Association between the interleukin-17A -197G>A (rs2275913) polymorphism and risk of digestive cancer.
Duan Y; Shi JN; Pan C; Chen HL; Zhang SZ
Asian Pac J Cancer Prev; 2014; 15(21):9295-300. PubMed ID: 25422215
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-23 receptor genetic polymorphisms and ulcerative colitis susceptibility: A meta-analysis.
Liu M; Zhu W; Wang J; Zhang J; Guo X; Wang J; Song J; Dong W
Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):516-25. PubMed ID: 25497273
[TBL] [Abstract][Full Text] [Related]
12. Lack of an association between interleukin-6 gene promoter polymorphisms (-174G/C, -572G/C) and ischemic heart disease and/or ischemic stroke: a meta-analysis.
Ma Y; Tang RK; Yang X; Peng GG; Liu Y; Wang XM; Wu BH; Yu JM
Hum Immunol; 2011 Aug; 72(8):641-51. PubMed ID: 21536090
[TBL] [Abstract][Full Text] [Related]
13. Lack of association of IL-10 gene polymorphisms with prostate cancer: evidence from 11,581 subjects.
Zou YF; Wang F; Feng XL; Tian YH; Tao JH; Pan FM; Huang F
Eur J Cancer; 2011 May; 47(7):1072-9. PubMed ID: 21211963
[TBL] [Abstract][Full Text] [Related]
14. Association between MTHFR gene polymorphisms (C677T, A1298C) and genetic susceptibility to prostate cancer: a meta-analysis.
Chen PL; Li WT; Wang J; Jiang YD; Wu P; Chen T; Zheng SB
Genet Mol Res; 2015 Dec; 14(4):19191-202. PubMed ID: 26782572
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 10 polymorphisms and cervical cancer risk: a meta-analysis.
Ni J; Ye Y; Teng F; Wu Q
Int J Gynecol Cancer; 2013 Jan; 23(1):126-33. PubMed ID: 23095823
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis on associations of IL-6 and IL-10 polymorphisms with susceptibility to ischemic stroke.
Chen M; Yang Y
J Neuroimmunol; 2019 Oct; 335():577004. PubMed ID: 31446341
[TBL] [Abstract][Full Text] [Related]
17. IL-6 -174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls.
Xu B; Niu XB; Wang ZD; Cheng W; Tong N; Mi YY; Min ZC; Tao J; Li PC; Zhang W; Wu HF; Zhang ZD; Wang ZJ; Hua LX; Feng NH; Wang XR
Mol Biol Rep; 2011 Apr; 38(4):2589-96. PubMed ID: 21104146
[TBL] [Abstract][Full Text] [Related]
18. Survivin rs9904341 polymorphism significantly increased the risk of cancer: evidence from an updated meta-analysis of case-control studies.
Moazeni-Roodi A; Ghavami S; Hashemi M
Int J Clin Oncol; 2019 Apr; 24(4):335-349. PubMed ID: 30747314
[TBL] [Abstract][Full Text] [Related]
19. Association between interleukin-6 polymorphisms and urinary system cancer risk: evidence from a meta-analysis.
Zhang K; Zhang L; Zhou J; Hao Z; Fan S; Yang C; Liang C
Onco Targets Ther; 2016; 9():567-77. PubMed ID: 26869801
[TBL] [Abstract][Full Text] [Related]
20. The -137G>C polymorphism in interleukin-18 promoter region and cancer risk: evidence from a meta-analysis of 21 studies.
Liang TJ; Ma H; Wang CX; Liu YR; Wang XG
Tumour Biol; 2013 Dec; 34(6):3483-90. PubMed ID: 23794112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
